Abstract: Provided herein are novel azopodophyllotoxin analog compounds, pharmaceutical compositions comprising them, and their use as inhibitors of Y box protein 1 (YB1 or YBX1) in treatments for conditions including gynecological, breast, bladder, kidney, head and neck, neuronal, and prostate cancers, lymphomas, and leukemias. Methods of their use in sensitizing resistant cancers to treatment with anticancer agents and radiation are also provided.

Abstract: A co-therapeutic regimen comprising AAV9-mediated intrathecal/intracisternal and/or systemic delivery of an expression cassette containing a hIDS gene and two or more immunosuppressants is provided herein. Also provided are methods and kits containing these vectors and compositions useful for treating Hunter syndrome and the symptoms associated with Hunter syndrome.

Abstract: Described herein is a method and system for controlling an interior-mounted permanent magnet (IPM) alternating-current (AC) electrical machine utilizing a space vector pulse-width modulated (SVPWM) converter operably connected between an electrical power source and the IPM AC electrical machine comprising three neural networks (NNs), including a controller NN operably connected to the SVPWM converter, a parameter estimator NN, and a flux-weakening and MTPA NN.

Abstract: Compositions and methods of capturing one or more nucleic acid molecules of a cell or subcellular compartment are described. In certain aspects, the compositions comprise a caged molecule comprising one or more photolinkers and an antisense oligonucleotide, which when uncaged hybridizes to a target nucleic acid molecule.

Abstract: Compounds and compositions for the transient expression of exogenous telomerase activity in a cell are provided. The compounds and compositions, which relate to a ribonucleic acid coding for a telomerase reverse transcriptase, are useful in the extension of telomeres in cells needing such treatment. Such cells include, for example, cells that contain shortened telomeres and cells from subjects that may benefit from telomere extension, for example subjects that suffer from, or are at risk of suffering from, age-related or other illnesses. Also provided are methods of extending telomeres through the administration of the provided compounds and compositions to animal cells, either in vitro or in vivo, and kits including the compounds or compositions and instructions for use.

Abstract: The invention provides compositions and methods for treating diseases associated with expression of CD20 or CD22. The invention also relates to chimeric antigen receptor (CAR) specific to CD20 or CD22, vectors encoding the same, and recombinant T or natural killer (NK) cells comprising the CD20 CAR or CD22 CAR. The invention also includes methods of administering a genetically modified T cell or NK cell expressing a CAR that comprises a CD20 or CD22 binding domain.

Abstract: A gradiometer includes a at least one magnet attached to a beam. The magnet moves in response to a magnetic force. A sensing element is configured to measure movement or deflection of the beam or magnet. The gradiometer is configured to determine a gradient of a magnetic field acting on the first magnet based on movement of the magnet. The gradiometer can further measure higher order gradients.

Abstract: Disclosed are methods, systems, device, and other implementations, including a method (performed by, for example, a hearing aid device) that includes obtaining a combined sound signal for signals combined from multiple sound sources in an area in which a person is located, and obtaining neural signals for the person, with the neural signals being indicative of one or more target sound sources, from the multiple sound sources, the person is attentive to. The method further includes determining a separation filter based, at least in part, on the neural signals obtained for the person, and applying the separation filter to a representation of the combined sound signal to derive a resultant separated signal representation associated with sound from the one or more target sound sources the person is attentive to.

Abstract: Presented herein are materials, methods, and systems for the improved 3D printing improved 3D printing of materials that include polypropylene. In some embodiments, the present disclosure provides a composite comprising a polymer matrix and a plurality of fibers for improved 3D printing. For example, the polymer matrix may have a composition that includes a polymer blend of polypropylene (PP) and polyethylene (PE) (e.g., high density polyethylene (HDPE), low density polyethylene (LDPE), linear low-density polyethylene (LLDPE)), impact modified polypropylene copolymer and/or polypropylene random copolymer with a plurality of fibers. In some embodiments, the plurality of fibers comprises cellulosic nanofibers (e.g., natural cellulosic nanofibers, e.g., cellulose nanofibrils). In some embodiments, filaments are prepared from the composites by melt compounding the polymer matrix (e.g., PP copolymers and/or PP/PE pellets) with a plurality of fibers and extruding the mixture.

Abstract: Arrays of single molecules and methods of producing an array of single molecules are described. Arrays with defined volumes between 10 attoliters and 50 picoliters enable single molecule detection and quantitation.

Abstract: As anode having an anode material, a current collector, a graphene-based material, and the graphene-based material covers the anode material.

Abstract: A multi-modal heart diagnostic system is provided. The diagnostic system can monitor heart activity and assists a user or operator in performing echocardiography. The system can include a positioning device that is placed on a patient's chest. The positioning device can incorporate several multi-modal sensors. The multi-modal sensors can measure different parameters associated with an assessment of heart activity. The multi-modal sensors can also be used to provide information that can assist an operator in positioning the probe within the positioning device to capture an echocardiogram.

Abstract: Systems and methods for managing and operating a water supply system in accordance with embodiments on the invention are described. In an embodiment, the system calculates a set of one or more marginal values for a water supply system by: determining a set of transmission marginal values for a transmission stage, determining a set of treatment marginal values for a treatment stage, and determining a set of distribution marginal values for a distribution stage for a set of consumers, where the determining includes backtracking consumed water to a set of one or more raw water sources, identifying a set of one or more marginal paths of water supply from each raw water source to the consumer, and quantifying the intensity of inputs associated with the marginal paths.

Abstract: Systems and methods for digitographic measurement of Parkinson's disease in accordance with embodiments of the invention are illustrated. One embodiment includes a digitographic measurement device, including a housing, a plurality of keys attached to the housing, a plurality of sensors, sensor in the plurality of sensors is associated with a key in the plurality of keys and is capable of measuring the amplitude of a key press, and an input/output interface within the housing, where the digitographic measurement device is configured to transmit key press data generated by the sensors to a controller via the input/output interface, and where the key press data is used to generate a plurality of digitographic metrics that describe motor symptoms of a user of the digitographic measurement device.

Abstract: Provided herein are chimeric transmembrane receptor polypeptides configured to oligomerize upon recognition of an extramembrane signal. The receptors include an extramembrane domain, a transmembrane domain, and an intramembrane domain configured to induce activation of one or more intramembrane signal pathways upon oligomerization of the receptor. The provided receptors are particularly useful for engineered cell therapies. Also provided are systems and host cells including the disclosed receptors, and methods for using the disclosed materials.

Abstract: Provided herein is a recombinant AAV (rAAV) comprising an AAV capsid and a vector genome packaged therein, wherein the vector genome comprises an AAV 5? inverted terminal repeat (ITR), an engineered nucleic acid sequence encoding a functional human N-acetyl-alpha-glucosaminidase (hNAGLU), a regulatory sequence which direct expression of hNAGLU in a target cell, and an AAV 3? ITR. Also provided is a pharmaceutical composition comprising a rAAV as described herein in a formulation buffer, and a method of treating a human subject diagnosed with MPS IIIB.

Abstract: Provided herein are compositions and methods for the fermentative production of 2,3-butanediol (2,3-BDO), compositions and methods for making methyl ethyl ketone (MEK), and methods of inducing drought tolerance in plants.

Abstract: Provided herein are compositions and methods to assess the genomic landscape of fixed cells using light activated oligonucleotides that can be directed to the nucleus, mitochondria, or cytoplasm of fixed cells and that, upon activation, can be extended for in situ copying of nuclear single-stranded DNA (i.e., open chromatin), open mitochondrial DNA, and/or cytoplasmic RNA into barcoded complementary DNA. These methods also provide for gene specific 3D chromatin structural niche analysis.

Abstract: A method of encoding a speech signal includes predicting a feature vector of each of a plurality of frames included in the speech signal based on a ground-truth feature vector of a previous frame of each of the plurality of frames, calculating a residual signal corresponding to each of the plurality of frames based on a ground-truth feature vector of each of the plurality of frames and a predicted feature vector of each of the plurality of frames, and generating a bitstring corresponding to each of the plurality of frames by quantizing the residual signal.

Abstract: Compositions and methods for treating diabetes in a canine are provided. A viral vector is provided which includes a nucleic acid molecule comprising a sequence encoding a canine insulin polypeptide.